Back
First National Financial Vs. Aligos Therapeutics Industry Stock Comparison
Sell
37
FN.TO
First National Financial
Last Price:
41.73
Seasonality Move:
2.98%
Buy
74
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Sell
37
First National Financial (FN.TO)
is a Sell
Is First National Financial a Buy, Sell or Hold?
- The current First National Financial [FN.TO] share price is $41.72. The Score for FN.TO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- FN.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $30.82. The Score for ALGS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FN.TO Stock Price Chart
What is First National Financial's stock price today?
-
The First National Financial share price today is $41.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FN.TO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FN.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 39.61 | Sell |
Chaikin Money Flow: | 970 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.26 - 44.24) | Sell |
Bollinger Bands (100): | (37.11 - 42.09) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.32 | Buy |
Relative Strength Index (14 RSI): | 81.62 | Buy |
Chaikin Money Flow: | 315379 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.3 - 26.46) | Buy |
Bollinger Bands (100): | (7.85 - 19.03) | Buy |
FN.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.71 | Sell |
20-day SMA: | 43.44 | Sell |
50-day SMA: | 41.63 | Buy |
200-day SMA: | 38.26 | Buy |
8-day EMA: | 42.61 | Sell |
20-day EMA: | 42.88 | Sell |
50-day EMA: | 41.78 | Sell |
200-day EMA: | 39.16 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.35 | Buy |
20-day SMA: | 22.81 | Buy |
50-day SMA: | 14.24 | Buy |
200-day SMA: | 15.81 | Buy |
8-day EMA: | 27.13 | Buy |
20-day EMA: | 22.88 | Buy |
50-day EMA: | 17.49 | Buy |
200-day EMA: | 15.94 | Buy |
First National Financial Earnings Growth & FN.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.50 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
First National Financial Technical Analysis
Nov 27 | Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |